David P. Schenkein

2019

In 2019, David P. Schenkein earned a total compensation of $2.6M as Former President and Chief Executive Officer Executive Chairman at Agios Pharmaceuticals, a 69% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$30,469
Option Awards$1,840,179
Salary$212,500
Stock Awards$489,951
Other$3,277
Total$2,576,376

Schenkein received $1.8M in option awards, accounting for 71% of the total pay in 2019.

Schenkein also received $30.5K in non-equity incentive plan, $212.5K in salary, $490K in stock awards and $3.3K in other compensation.

Rankings

In 2019, David P. Schenkein's compensation ranked 4,733rd out of 13,971 executives tracked by ExecPay. In other words, Schenkein earned more than 66.1% of executives.

ClassificationRankingPercentile
All
4,733
out of 13,971
66th
Division
Manufacturing
1,764
out of 5,692
69th
Major group
Chemicals And Allied Products
614
out of 2,189
72nd
Industry group
Drugs
517
out of 1,875
72nd
Industry
Pharmaceutical Preparations
389
out of 1,387
72nd

Pay ratio

David P. Schenkein's Pay$2,576,376
Median Employee's Pay$267,104
Pay Ratio

10

to 1

In 2019, the annual total compensation of David P. Schenkein was $2,576,376.

The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.

The ratio of David P. Schenkein's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 16, 2020.

Schenkein's colleagues

We found five more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2019.

2019

Jacqualyn Fouse

Agios Pharmaceuticals

Chief Executive Officer

2019

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2019

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2019

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2019

Jonathan Biller

Agios Pharmaceuticals

Chief Legal Officer

News

In-depth

You may also like